Peripheral Stent

Peripheral Stent Market Outlook

The global peripheral stent market is anticipated to reach approximately USD 5.2 billion by 2035, with a compound annual growth rate (CAGR) of around 6.5% from 2025 to 2035. The driving forces behind this growth include the increasing prevalence of peripheral vascular diseases, the rising geriatric population, and the advancements in stent technology that enhance patient outcomes and procedural efficacy. Moreover, the growing awareness around early diagnosis and treatment of vascular disorders is contributing significantly to the market's expansion. Increased spending on healthcare infrastructure and the availability of advanced medical devices are also pivotal factors pushing the growth of the peripheral stent market. The ongoing research and development activities aimed at improving stent designs and materials are expected to further bolster market opportunities.

Growth Factor of the Market

One of the principal growth factors of the peripheral stent market is the alarming rise in the incidence of lifestyle-related diseases such as diabetes and hypertension, which are significant risk factors for peripheral artery disease (PAD). Furthermore, the aging population, particularly in developed regions, has been identified as a crucial demographic contributing to the increase in vascular-related conditions, leading to higher demand for peripheral stenting procedures. The continuous advancements in technologies, including the development of drug-eluting stents with improved features and biocompatibility, are also fostering market growth. Additionally, the increasing number of interventional procedures and a growing preference for minimally invasive surgeries are propelling the adoption of peripheral stents in various healthcare settings. The expansion of healthcare facilities and the rising number of trained professionals are vital in enhancing patient access to these innovative vascular solutions.

Key Highlights of the Market

• The global peripheral stent market is projected to witness significant growth due to rising incidences of peripheral vascular diseases.
• Technological advancements, particularly in drug-eluting stent designs, are expected to transform procedural outcomes.
• The increasing elderly population is likely to drive demand for peripheral stenting interventions.
• There is a growing trend towards minimally invasive surgical methods, enhancing the adoption of peripheral stents.
• Emerging markets are progressively becoming key players in terms of market expansion due to improved healthcare infrastructure.

By Product Type

Balloon-expandable Stents :

Balloon-expandable stents are widely recognized for their substantial role in the peripheral stent market. These stents are deployed by inflating a balloon within the stent, which expands it against the vessel wall. This type of stent is particularly effective for treating lesions in arteries that require precise control during placement. They are also favored due to their proven efficacy and durability over time. As medical professionals gain more experience with this technology, the demand for balloon-expandable stents is expected to rise significantly. The ability to customize these stents based on patient-specific needs further enhances their popularity, making them a prominent choice among healthcare providers.

Self-expandable Stents :

Self-expandable stents have gained traction in the peripheral stent market due to their unique deployment mechanism. These stents are designed to expand automatically once deployed, allowing for easier and faster placement, which is particularly beneficial in cases where immediate blood flow restoration is required. Their flexibility and adaptability to varying vessel diameters make them suitable for a wide range of applications. Furthermore, advancements in the materials used for these stents have improved their performance and reduced complications associated with implantation. As healthcare providers continue to explore options that enhance patient outcomes, self-expandable stents are likely to witness sustained growth in demand.

Drug-eluting Stents :

Drug-eluting stents (DES) have revolutionized the treatment of peripheral artery disease by incorporating medication that helps prevent restenosis. These stents release drugs locally to inhibit cell proliferation, thereby reducing the likelihood of scar tissue formation within the artery. This innovative approach results in improved long-term patency rates compared to traditional stents. The increasing emphasis on patient safety and outcomes drives the adoption of drug-eluting stents in clinical settings. Furthermore, continued research into new drug formulations and stent designs promises to enhance the effectiveness of these devices even further, solidifying their position in the market.

Bare-metal Stents :

Bare-metal stents are considered the original form of stenting and continue to be utilized in various procedures. These stents are typically made from metal alloys and do not have any drug coating. While they are less effective than drug-eluting stents in preventing restenosis, they remain an important option in certain clinical cases, particularly where cost is a significant factor. The simplicity of their design and the absence of drug-related complications make bare-metal stents a viable choice for specific patient populations. Moreover, their long history of clinical use provides a level of familiarity among healthcare providers, contributing to their continued presence in the market.

Bioresorbable Stents :

Bioresorbable stents represent a groundbreaking advancement in stent technology. These stents are designed to gradually dissolve over time, eliminating the need for permanent implants within the body. This property significantly reduces the risk of long-term complications associated with traditional stenting options, such as late thrombosis and restenosis. Bioresorbable stents are particularly appealing for patients who require temporary support during the healing process. As clinical evidence supporting their effectiveness continues to evolve, these stents are emerging as a promising alternative to conventional stents, thereby expanding their share in the market.

By Application

Iliac Artery :

Stenting applications in the iliac artery are critical, as this region is often affected by atherosclerosis, leading to significant arterial occlusion. The use of peripheral stents in this area aims to restore adequate blood flow to the lower extremities, thus alleviating symptoms such as claudication and ischemia. The increasing prevalence of peripheral vascular diseases, particularly among the aging population, has spurred demand for iliac artery stenting procedures. As techniques and technologies continue to improve, the success rates of these interventions are also expected to rise, fostering a greater acceptance of iliac artery stenting within the medical community.

Femoral Artery :

Femoral artery stenting is another prominent application within the peripheral stent market. This artery is frequently targeted due to its involvement in numerous vascular issues, including acute limb ischemia and chronic occlusion. Employing stents in the femoral artery can significantly improve blood flow and enhance patient mobility. The development of specialized stents that cater specifically to the unique anatomical challenges posed by the femoral artery has elevated procedural success rates. Moreover, advancements in imaging techniques and preoperative assessments facilitate the accurate placement of stents, which further enhances the effectiveness of femoral artery interventions.

Popliteal Artery :

Stenting of the popliteal artery is essential in managing conditions affecting blood flow to the knee region and lower leg. Similar to the iliac and femoral arteries, occlusions in the popliteal artery can lead to severe complications, necessitating timely intervention through stenting. The use of tailored stent designs for the popliteal artery, considering its unique curvature and anatomical challenges, has significantly improved treatment outcomes. Additionally, the increasing prevalence of vascular diseases and the demand for effective management solutions are expected to drive the growth of this application segment in the peripheral stent market.

Renal Artery :

Renal artery stenting plays a crucial role in the management of renal artery stenosis, a condition that can lead to significant complications such as hypertension and renal impairment. The introduction of stents in the renal arteries has proven to be an effective approach to restoring blood flow and improving kidney function. The increasing incidence of conditions such as diabetes and atherosclerosis, which contribute to renal artery stenosis, continues to fuel the demand for stenting procedures in this application. Additionally, the advancements in imaging and catheter technologies have significantly enhanced the precision of renal artery stenting, thereby improving patient outcomes.

Carotid Artery :

Carotid artery stenting is instrumental in preventing strokes by addressing carotid artery stenosis. This application has gained immense attention due to the high risk of cerebrovascular events associated with untreated carotid artery disease. The development of specialized carotid stents, combined with sophisticated delivery systems, has facilitated safer and more effective interventions. The ongoing research into the long-term benefits of carotid artery stenting compared to traditional surgical options continues to bolster its acceptance in clinical practice. As awareness around stroke prevention grows, the demand for carotid artery stenting is expected to rise, further solidifying its position in the peripheral stent market.

By Distribution Channel

Hospitals :

Hospitals are the primary distribution channel for peripheral stents, primarily due to their extensive resources and advanced medical facilities. These institutions are equipped to perform complex vascular procedures and have access to the latest stenting technologies. The growing number of patients seeking treatment for vascular diseases, combined with the hospital's capacity to manage such cases, is driving the demand for peripheral stents. Additionally, hospitals often collaborate with leading manufacturers to provide the most advanced devices, ensuring that patients receive optimal care. As the healthcare landscape evolves, hospitals are likely to continue leading the market in terms of peripheral stent distribution.

Ambulatory Surgical Centers :

Ambulatory surgical centers (ASCs) have emerged as a vital distribution channel for peripheral stents, primarily due to the rising trend of outpatient surgeries. These centers provide patients with a cost-effective alternative to traditional hospital settings while ensuring quality care and shorter recovery times. As healthcare policies increasingly promote outpatient procedures, ASCs have become a popular choice for vascular interventions, leading to an uptick in demand for peripheral stents. The convenience offered by ASCs, combined with advancements in minimally invasive techniques, positions them as a notable player in the peripheral stent distribution landscape.

Specialty Clinics :

Specialty clinics focusing on vascular health are becoming increasingly significant in the distribution of peripheral stents. These clinics provide specialized care and are often staffed by experts in vascular interventions, ensuring that patients receive tailored treatment. The growing awareness of peripheral vascular diseases has led to an increase in patient referrals to these clinics, further driving demand for peripheral stents. Additionally, the ability of specialty clinics to offer advanced diagnostic and treatment options enhances their appeal, making them a critical component of the overall market distribution network.

Online Stores :

The advent of e-commerce has transformed the distribution landscape for peripheral stents, with online stores providing another viable channel for procurement. Healthcare professionals are increasingly turning to online platforms for the convenience of ordering stents and related devices. This shift is attributed to the ease of access to a wide variety of products, comparative pricing, and streamlined purchasing processes. However, the online distribution of medical devices is subject to strict regulations, ensuring that only approved products reach healthcare providers. As the market evolves, the role of online stores in distributing peripheral stents is likely to expand, driven by the ongoing digitization of the healthcare supply chain.

Retail Pharmacies :

Retail pharmacies play a complementary role in the distribution of peripheral stents, particularly in the context of post-procedural care. While stenting procedures are primarily conducted in hospitals and specialty clinics, retail pharmacies provide necessary follow-up medications and supplies to patients recovering from vascular interventions. The convenience of having access to medications and support in local pharmacies enhances patient adherence to treatment plans. Moreover, as healthcare systems increasingly aim to provide comprehensive care, the role of retail pharmacies in educating patients about their conditions and treatment options is becoming increasingly prominent. Thus, while their primary role may not be in direct stent distribution, retail pharmacies hold significant importance in the overall care continuum.

By Material Type

Metallic Stents :

Metallic stents are the most widely used type of peripheral stents, known for their strength and durability. These stents are typically made from various metal alloys, which provide the necessary structural integrity to support the artery once implanted. Their proven track record and historical use in numerous vascular procedures have solidified their position in the market. Despite the emergence of new materials, metallic stents remain a staple due to their effectiveness in treating a wide range of vascular conditions. Continuous advancements in metallic stent design and manufacturing processes further enhance their performance, ensuring their ongoing relevance in the peripheral stent market.

Polymer Stents :

Polymer stents have emerged as a popular alternative to traditional metallic stents. Their lightweight nature and biocompatibility make them an attractive option for various vascular interventions. Additionally, polymer stents can be coated with drugs, further enhancing their efficacy in preventing restenosis. The flexibility of polymer materials allows for the development of stents that conform better to the natural contours of the blood vessels, promoting improved patient outcomes. As research into innovative polymer formulations continues, the demand for polymer stents is expected to grow significantly, positioning them as a key segment within the peripheral stent market.

Bioresorbable Stents :

Bioresorbable stents represent a cutting-edge advancement in vascular treatment, designed to dissolve gradually over time after serving their purpose. This unique feature eliminates the need for permanent implants, reducing the long-term risks associated with traditional stenting approaches. Bioresorbable stents provide temporary scaffolding for the artery while allowing natural healing to occur. As more clinical studies demonstrate their effectiveness and safety, the adoption of bioresorbable stents is gaining momentum. Their ability to minimize long-term complications makes them a crucial part of the ongoing evolution within the peripheral stent market, appealing to both healthcare providers and patients seeking innovative solutions.

Others :

The category "Others" encompasses various emerging materials and technologies utilized in the production of peripheral stents. This segment includes hybrid stents, which combine the benefits of both metallic and polymer materials, as well as stents integrated with advanced coatings aimed at improving biocompatibility and reducing thrombosis risk. The exploration of novel materials and technologies in the peripheral stent market represents a significant area of innovation, with ongoing research focused on enhancing the performance and effectiveness of these devices. As the market evolves, the "Others" segment is likely to gain traction as manufacturers continue to develop cutting-edge solutions to address the limitations of traditional stents.

By Region

The North American region is anticipated to dominate the peripheral stent market, accounting for approximately 40% of the global share by 2035. The robust healthcare infrastructure, coupled with high healthcare expenditure and advanced medical technologies, contributes to this dominant position. Moreover, the increasing prevalence of peripheral vascular diseases, particularly among the aging population, propels the demand for peripheral stenting procedures in this region. The presence of key players in the market and ongoing research activities aimed at developing innovative stenting solutions further bolster the North American market. The region's CAGR is projected to be around 6.0%, reflecting steady growth as the demand for advanced vascular interventions continues to rise.

Europe holds the second-largest share of the peripheral stent market, accounting for approximately 30% of the global revenue. Factors such as an increasing number of interventional procedures and a growing awareness of peripheral vascular diseases are driving market growth in this region. The European market is characterized by a shift towards minimally invasive surgical techniques, which has led to the rising adoption of advanced stenting devices. Furthermore, government initiatives aimed at improving healthcare access and outcomes are expected to contribute positively to market growth in Europe. The region is forecasted to experience a CAGR of around 5.5%, indicating a steady upward trajectory as medical advancements continue to enhance patient care.

Opportunities

The peripheral stent market is poised for numerous opportunities driven by technological advancements and an increasing focus on patient outcomes. One of the most significant opportunities lies in the development of advanced stenting technologies, such as bioresorbable and drug-eluting stents, which promise improved long-term results and reduced complications. Manufacturers are investing in research and development to create innovative designs that enhance stent performance and patient compatibility. Additionally, the expansion of healthcare facilities in emerging markets presents a lucrative opportunity for stakeholders in the peripheral stent market. As these regions develop their healthcare infrastructure, the demand for advanced medical devices is expected to surge, encouraging manufacturers to explore new markets and partnerships.

Moreover, ongoing awareness campaigns and education initiatives focused on peripheral vascular diseases are likely to increase patient referrals for stenting procedures. As healthcare providers emphasize the importance of early diagnosis and intervention, the adoption of peripheral stents is expected to grow. The integration of telemedicine and digital health solutions into vascular care also presents opportunities for enhancing patient engagement and monitoring post-procedural outcomes. By leveraging these technologies, healthcare providers can improve the overall patient experience, leading to higher satisfaction rates and better long-term outcomes. Collectively, these factors create a favorable environment for growth and innovation within the peripheral stent market.

Threats

Despite the promising growth trajectory of the peripheral stent market, several threats could hinder its progress. One of the primary threats is the stringent regulatory environment governing the approval and distribution of medical devices. The lengthy approval processes and comprehensive testing requirements can delay the introduction of new products, restricting market entry for innovative stent technologies. Additionally, the increasing competition from alternative treatment modalities and advancements in non-invasive therapies may pose a challenge to the market. As healthcare providers explore diverse treatment options, the demand for peripheral stents may face pressure, particularly in regions where cost-effectiveness is a significant concern.

Moreover, the prevalence of complications associated with stenting, such as thrombosis and restenosis, can discourage both healthcare providers and patients from opting for these devices. Public perception regarding the safety and efficacy of stents can further impact their adoption. Continuous monitoring and addressing these complications through improved designs and materials will be essential for maintaining confidence in peripheral stenting procedures. Additionally, fluctuations in the global economy and healthcare spending may also affect the market, as budget constraints in healthcare systems could limit access to advanced stenting technologies. Navigating these threats will require vigilance and adaptability from industry stakeholders to ensure sustained growth in the peripheral stent market.

Competitor Outlook

• Boston Scientific Corporation
• Medtronic PLC
• Abbott Laboratories
• Johnson & Johnson
• B. Braun Melsungen AG
• Terumo Corporation
• Cordis Corporation
• Cook Medical
• St. Jude Medical, Inc.
• Cardinal Health, Inc.
• AngioDynamics, Inc.
• InspireMD, Inc.
• MicroPort Scientific Corporation
• Endologix, Inc.
• SurModics, Inc.

The competitive landscape of the peripheral stent market is characterized by a mix of established players and emerging companies focused on innovation and differentiation. Major companies like Boston Scientific Corporation, Medtronic PLC, and Abbott Laboratories lead the market, leveraging their advanced research capabilities and extensive product portfolios to capture significant market share. These companies continuously invest in research and development to introduce cutting-edge stenting technologies, including drug-eluting and bioresorbable stents, addressing the evolving needs of healthcare providers and patients. Their robust distribution networks and strategic partnerships further enhance their competitive positioning within the market.

Emerging players and smaller companies like InspireMD and Endologix are also gaining traction by focusing on niche markets and developing specialized stenting solutions. These companies are capitalizing on the growing demand for minimally invasive vascular interventions and are exploring unique product offerings that cater to specific patient populations. The competitive dynamics of the market are driven by the need for continuous innovation, as companies strive to differentiate themselves through advanced product features and improved patient outcomes. Collaborations and acquisitions within the industry are also prevalent as companies seek to expand their market presence and enhance their technological capabilities.

In summary, the peripheral stent market is a dynamic and competitive landscape, with both established and emerging players vying for market share. As the demand for advanced vascular treatment options continues to grow, companies that prioritize innovation, patient-centric approaches, and strategic partnerships are likely to thrive. With the market evolving rapidly, ongoing investments in research and development and a keen focus on addressing the challenges of vascular diseases will be pivotal for companies looking to maintain a competitive edge in this expanding market.

• 1 Appendix

  • 1.1 List of Tables
  • 1.2 List of Figures

• 2 Introduction

  • 2.1 Market Definition
  • 2.2 Scope of the Report
  • 2.3 Study Assumptions
  • 2.4 Base Currency & Forecast Periods

• 3 Market Dynamics

  • 3.1 Market Growth Factors
  • 3.2 Economic & Global Events
  • 3.3 Innovation Trends
  • 3.4 Supply Chain Analysis

• 4 Consumer Behavior

  • 4.1 Market Trends
  • 4.2 Pricing Analysis
  • 4.3 Buyer Insights

• 5 Key Player Profiles

  • 5.1 Cook Medical
    • 5.1.1 Business Overview
    • 5.1.2 Products & Services
    • 5.1.3 Financials
    • 5.1.4 Recent Developments
    • 5.1.5 SWOT Analysis
  • 5.2 Medtronic PLC
    • 5.2.1 Business Overview
    • 5.2.2 Products & Services
    • 5.2.3 Financials
    • 5.2.4 Recent Developments
    • 5.2.5 SWOT Analysis
  • 5.3 Endologix, Inc.
    • 5.3.1 Business Overview
    • 5.3.2 Products & Services
    • 5.3.3 Financials
    • 5.3.4 Recent Developments
    • 5.3.5 SWOT Analysis
  • 5.4 InspireMD, Inc.
    • 5.4.1 Business Overview
    • 5.4.2 Products & Services
    • 5.4.3 Financials
    • 5.4.4 Recent Developments
    • 5.4.5 SWOT Analysis
  • 5.5 SurModics, Inc.
    • 5.5.1 Business Overview
    • 5.5.2 Products & Services
    • 5.5.3 Financials
    • 5.5.4 Recent Developments
    • 5.5.5 SWOT Analysis
  • 5.6 Johnson & Johnson
    • 5.6.1 Business Overview
    • 5.6.2 Products & Services
    • 5.6.3 Financials
    • 5.6.4 Recent Developments
    • 5.6.5 SWOT Analysis
  • 5.7 Cordis Corporation
    • 5.7.1 Business Overview
    • 5.7.2 Products & Services
    • 5.7.3 Financials
    • 5.7.4 Recent Developments
    • 5.7.5 SWOT Analysis
  • 5.8 Terumo Corporation
    • 5.8.1 Business Overview
    • 5.8.2 Products & Services
    • 5.8.3 Financials
    • 5.8.4 Recent Developments
    • 5.8.5 SWOT Analysis
  • 5.9 Abbott Laboratories
    • 5.9.1 Business Overview
    • 5.9.2 Products & Services
    • 5.9.3 Financials
    • 5.9.4 Recent Developments
    • 5.9.5 SWOT Analysis
  • 5.10 AngioDynamics, Inc.
    • 5.10.1 Business Overview
    • 5.10.2 Products & Services
    • 5.10.3 Financials
    • 5.10.4 Recent Developments
    • 5.10.5 SWOT Analysis
  • 5.11 B. Braun Melsungen AG
    • 5.11.1 Business Overview
    • 5.11.2 Products & Services
    • 5.11.3 Financials
    • 5.11.4 Recent Developments
    • 5.11.5 SWOT Analysis
  • 5.12 Cardinal Health, Inc.
    • 5.12.1 Business Overview
    • 5.12.2 Products & Services
    • 5.12.3 Financials
    • 5.12.4 Recent Developments
    • 5.12.5 SWOT Analysis
  • 5.13 St. Jude Medical, Inc.
    • 5.13.1 Business Overview
    • 5.13.2 Products & Services
    • 5.13.3 Financials
    • 5.13.4 Recent Developments
    • 5.13.5 SWOT Analysis
  • 5.14 Boston Scientific Corporation
    • 5.14.1 Business Overview
    • 5.14.2 Products & Services
    • 5.14.3 Financials
    • 5.14.4 Recent Developments
    • 5.14.5 SWOT Analysis
  • 5.15 MicroPort Scientific Corporation
    • 5.15.1 Business Overview
    • 5.15.2 Products & Services
    • 5.15.3 Financials
    • 5.15.4 Recent Developments
    • 5.15.5 SWOT Analysis

• 6 Market Segmentation

  • 6.1 Peripheral Stent Market, By Application
    • 6.1.1 Iliac Artery
    • 6.1.2 Femoral Artery
    • 6.1.3 Popliteal Artery
    • 6.1.4 Renal Artery
    • 6.1.5 Carotid Artery
  • 6.2 Peripheral Stent Market, By Product Type
    • 6.2.1 Balloon-expandable Stents
    • 6.2.2 Self-expandable Stents
    • 6.2.3 Drug-eluting Stents
    • 6.2.4 Bare-metal Stents
    • 6.2.5 Bioresorbable Stents
  • 6.3 Peripheral Stent Market, By Material Type
    • 6.3.1 Metallic Stents
    • 6.3.2 Polymer Stents
    • 6.3.3 Bioresorbable Stents
    • 6.3.4 Others
  • 6.4 Peripheral Stent Market, By Distribution Channel
    • 6.4.1 Hospitals
    • 6.4.2 Ambulatory Surgical Centers
    • 6.4.3 Specialty Clinics
    • 6.4.4 Online Stores
    • 6.4.5 Retail Pharmacies

• 7 Competitive Analysis

  • 7.1 Key Player Comparison
  • 7.2 Market Share Analysis
  • 7.3 Investment Trends
  • 7.4 SWOT Analysis

• 8 Research Methodology

  • 8.1 Analysis Design
  • 8.2 Research Phases
  • 8.3 Study Timeline

• 9 Future Market Outlook

  • 9.1 Growth Forecast
  • 9.2 Market Evolution

• 10 Geographical Overview

  • 10.1 Europe - Market Analysis
    • 10.1.1 By Country
      • 10.1.1.1 UK
      • 10.1.1.2 France
      • 10.1.1.3 Germany
      • 10.1.1.4 Spain
      • 10.1.1.5 Italy
  • 10.2 Asia Pacific - Market Analysis
    • 10.2.1 By Country
      • 10.2.1.1 India
      • 10.2.1.2 China
      • 10.2.1.3 Japan
      • 10.2.1.4 South Korea
  • 10.3 Latin America - Market Analysis
    • 10.3.1 By Country
      • 10.3.1.1 Brazil
      • 10.3.1.2 Argentina
      • 10.3.1.3 Mexico
  • 10.4 North America - Market Analysis
    • 10.4.1 By Country
      • 10.4.1.1 USA
      • 10.4.1.2 Canada
  • 10.5 Peripheral Stent Market by Region
  • 10.6 Middle East & Africa - Market Analysis
    • 10.6.1 By Country
      • 10.6.1.1 Middle East
      • 10.6.1.2 Africa

• 11 Global Economic Factors

  • 11.1 Inflation Impact
  • 11.2 Trade Policies

• 12 Technology & Innovation

  • 12.1 Emerging Technologies
  • 12.2 AI & Digital Trends
  • 12.3 Patent Research

• 13 Investment & Market Growth

  • 13.1 Funding Trends
  • 13.2 Future Market Projections

• 14 Market Overview & Key Insights

  • 14.1 Executive Summary
  • 14.2 Key Trends
  • 14.3 Market Challenges
  • 14.4 Regulatory Landscape

Segments Analyzed in the Report

The global Peripheral Stent market is categorized based on

By Product Type

• Balloon-expandable Stents
• Self-expandable Stents
• Drug-eluting Stents
• Bare-metal Stents
• Bioresorbable Stents

By Application

• Iliac Artery
• Femoral Artery
• Popliteal Artery
• Renal Artery
• Carotid Artery

By Distribution Channel

• Hospitals
• Ambulatory Surgical Centers
• Specialty Clinics
• Online Stores
• Retail Pharmacies

By Material Type

• Metallic Stents
• Polymer Stents
• Bioresorbable Stents
• Others

By Region

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East & Africa

Key Players

• Boston Scientific Corporation
• Medtronic PLC
• Abbott Laboratories
• Johnson & Johnson
• B. Braun Melsungen AG
• Terumo Corporation
• Cordis Corporation
• Cook Medical
• St. Jude Medical, Inc.
• Cardinal Health, Inc.
• AngioDynamics, Inc.
• InspireMD, Inc.
• MicroPort Scientific Corporation
• Endologix, Inc.
• SurModics, Inc.